Close Menu

NEW YORK – Pressure Biosciences (PBI) said Tuesday that it has entered into a global comarketing agreement with Danaher company Leica Microsystems for a mass spectrometry sample preparation platform.

The platform combines Leica's laser microdissection (LMD) technology, which allows for precise cutting of small biopsy samples, and South Easton, Massachusetts-based PBI's pressure cycling technology (PCT), which aids extraction and digestion of proteins from samples prior to mass spec analysis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Wall Street Journal, the Food and Drug Administration may soon issue an Emergency Use Authorization for convalescent plasma to treat COVID-19 patients.

Minnesota police have used genetic genealogy to make an arrest in a 1986 cold case, reports NBC News.

Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.

In Science this week: chromatin accessibility of microglia during fetal development, and more.

Sep
09
Sponsored by
10x Genomics

Recent advances in spatially resolved transcriptomics have greatly expanded the knowledge of complex multicellular biological systems.